Our company is a comprehensive enterprise integrating R&D, manufacturing, and international trade of biopharmaceuticals and fine chemicals. With years of deep cultivation in the industry, we have always adhered to the core philosophy of "innovation-driven, quality first, integrity and mutual benefit." Focusing on the high-end chemical and biopharmaceutical sectors, we provide global customers with one-stop, customized products and technical services, supporting the high-quality development of pharmaceutical, chemical, and related industries.
Our core business covers three major series: aldehydes, heterocyclic aromatics, and saccharides, while also offering a wide range of high-quality customized products to precisely meet the diverse needs of different customers. Representative products include 3-(tert-butyl-dimethyl-silanyloxy)-propionaldehyde, tert-butyl (5-hydroxypentyl)(methyl)carbamate, 5-((tert-butoxycarbonyl)(methyl)amino)pentanoic acid, 2,4-dichloro-1,5-naphthyridine, tert-butyl 4-formyl-1H-imidazole-1-carboxylate, 1-cyclopropyl-1,2,3,4-tetrahydroquinoxaline, 5-bromo-4,6-dimethylnicotinic acid, lilial, 4-cyclopropyl-2-(methylthio)oxazole, 4-penten-2-ol, and others. These products are widely used in drug discovery, API synthesis, fine chemical manufacturing, advanced material preparation, and other fields. Recognized for their high purity and high stability, they have earned consistent recognition from domestic and international customers.
To ensure the professionalism and stability of product R&D and manufacturing, the company has established a comprehensive R&D and production system. The R&D laboratories are located in two core areas of Shanghai—Pudong and Fengxian District—equipped with advanced laboratory facilities and a professional R&D team, focusing on cutting-edge technological breakthroughs and product upgrades to continuously enhance core competitiveness. The production base is situated in Shandong Province, featuring standardized production workshops,规范化 warehousing facilities, and mature production lines. It strictly follows industry standards and quality control systems, achieving closed-loop management across the entire process from raw material procurement, production and processing, to final product inspection, ensuring that product quality consistently meets customer requirements.
Looking ahead, the company will continue to deepen its presence in the biopharmaceutical and fine chemical sectors, increase R&D investment, expand product categories, optimize production layout, and strengthen international trade cooperation. We are committed to becoming a comprehensive enterprise with core influence in the industry and contributing to the development of the global pharmaceutical and chemical industry.

